Related Experiment Video
Updated: Apr 15, 2026

A Murine Model of Group B Streptococcus Vaginal Colonization
Published on: November 16, 2016
Burden of invasive group B Streptococcus disease and early neurological sequelae in South African infants
Ziyaad Dangor1, Sanjay G Lala2, Clare L Cutland3
1Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Gauteng, South Africa; Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Gauteng, South Africa; Department of Paediatrics, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Gauteng, South Africa.
Insights
Group B Streptococcus (GBS) causes significant infant illness, with HIV-exposed infants facing a higher risk of late-onset disease. Vaccination could prevent GBS infections and their severe outcomes in newborns.
Area of Science:
- Neonatal infectious diseases
- Epidemiology of GBS
- HIV and infant health
Background:
- Group B Streptococcus (GBS) is a major cause of neonatal sepsis and meningitis.
- High prevalence of HIV in pregnant women presents a unique challenge for GBS disease management.
- Understanding GBS burden and risk factors is crucial for prevention strategies.
Purpose of the Study:
- To evaluate the burden of invasive early-onset (EOD) and late-onset (LOD) GBS disease in infants.
- To assess the risk of neurological sequelae in infants with invasive GBS disease.
- To investigate the impact of maternal HIV status on GBS disease incidence and outcomes.
Main Methods:
- A case-control study was conducted in Johannesburg, South Africa.
- Invasive GBS cases in infants under 3 months were identified through laboratory surveillance.
- Neurodevelopmental screening was performed on surviving cases and controls at 3 and 6 months of age.
Main Results:
- 122 cases of invasive GBS disease were identified.
- HIV-exposed infants had a significantly higher risk of late-onset GBS disease (4.67-fold increase).
- Neurological sequelae were significantly more common in GBS cases (13.2%) compared to controls (0.4%).
Conclusions:
- Invasive GBS disease poses a high burden in South Africa, with significant mortality and long-term neurological effects.
- Increased risk of late-onset GBS disease in infants of HIV-infected mothers contributes to the overall burden.
- A GBS conjugate vaccine targeting pregnant women could be an effective preventive measure.
Introduction:
Group B Streptococcus (GBS) is a leading cause of neonatal sepsis and meningitis. We aimed to evaluate the burden of invasive early-onset (0-6 days of life, EOD) and late-onset (7-89 days, LOD) GBS disease and subsequent neurological sequelae in infants from a setting with a high prevalence (29.5%) of HIV among pregnant women.
Methods:
A case-control study was undertaken at three secondary-tertiary care public hospitals in Johannesburg. Invasive cases in infants <3 months age were identified by surveillance of laboratories from November 2012 to February 2014. Neurodevelopmental screening was done in surviving cases and controls at 3 and 6 months of age.
Results:
We identified 122 cases of invasive GBS disease over a 12 month period. Although the incidence (per 1,000 live births) of EOD was similar between HIV-exposed and HIV-unexposed infants (1.13 vs. 1.46; p = 0.487), there was a 4.67-fold (95%CI: 2.24-9.74) greater risk for LOD in HIV-exposed infants (2.27 vs. 0.49; p<0.001). Overall, serotypes Ia, Ib and III constituted 75.8% and 92.5% of EOD and LOD, respectively. Risk factors for EOD included offensive draining liquor (adjusted Odds Ratio: 27.37; 95%CI: 1.94-386.50) and maternal GBS bacteriuria (aOR: 8.41; 95%CI: 1.44-49.15), which was also a risk-factor for LOD (aOR: 3.49; 95%CI: 1.17-10.40). The overall case fatality rate among cases was 18.0%. The adjusted odds for neurological sequelae at 6 months age was 13.18-fold (95%CI: 1.44-120.95) greater in cases (13.2%) than controls (0.4%).
Discussion:
The high burden of invasive GBS disease in South Africa, which is also associated with high case fatality rates and significant neurological sequelae among survivors, is partly due to the heightened risk for LOD in infants born to HIV-infected women. An effective trivalent GBS conjugate vaccine targeted at pregnant women could prevent invasive GBS disease in this setting.
Related Concept Videos
Development of the Oral Microbiota
Viral Meningitis
Development of Human Microbiota

